Standard
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines. / Stougaard, E. Buur; Vistisen, D.; Persson, F.; Rossing, P.
In:
Diabetologia, Vol. 64, No. SUPPL 1, 606, 09.2021, p. 319-319.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Stougaard, EB, Vistisen, D, Persson, F
& Rossing, P 2021, '
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines',
Diabetologia, vol. 64, no. SUPPL 1, 606, pp. 319-319.
https://doi.org/10.1007/s00125-021-05519-yAPA
Stougaard, E. B., Vistisen, D., Persson, F.
, & Rossing, P. (2021).
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines.
Diabetologia,
64(SUPPL 1), 319-319. [606].
https://doi.org/10.1007/s00125-021-05519-yVancouver
Stougaard EB, Vistisen D, Persson F
, Rossing P.
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines.
Diabetologia. 2021 Sep;64(SUPPL 1):319-319. 606.
https://doi.org/10.1007/s00125-021-05519-yAuthor
Stougaard, E. Buur ; Vistisen, D. ; Persson, F. ; Rossing, P. / Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines. In: Diabetologia. 2021 ; Vol. 64, No. SUPPL 1. pp. 319-319.
Bibtex
@article{7d50558d36044a79a4a27de8eb2b38ff,
title = "Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines",
author = "Stougaard, {E. Buur} and D. Vistisen and F. Persson and P. Rossing",
year = "2021",
month = sep,
doi = "10.1007/s00125-021-05519-y",
language = "English",
volume = "64",
pages = "319--319",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "SUPPL 1",
}
RIS
TY - ABST
T1 - Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines
AU - Stougaard, E. Buur
AU - Vistisen, D.
AU - Persson, F.
AU - Rossing, P.
PY - 2021/9
Y1 - 2021/9
U2 - 10.1007/s00125-021-05519-y
DO - 10.1007/s00125-021-05519-y
M3 - Conference abstract in journal
C2 - 34468792
VL - 64
SP - 319
EP - 319
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - SUPPL 1
M1 - 606
ER -
